Skip to main content
Fig. 3 | BMC Urology

Fig. 3

From: Anti-tumor effects of a recombinant anti-prostate specific membrane antigen immunotoxin against prostate cancer cells

Fig. 3

Immunocasp-3 fusion proteins inhibit the growth of LNCaP cells. a: Electronic microscopy of LNCaP 48 h after transfection of immunocasp-3. b: 48 h after transfection, LNCaP cells were subjected to Annexin V-FITC staining concomitant with 4,6-diamidino-2-phenylindole nucleus staining and analyzed by flow cytometry. c: LNCaP cells were cocultured with immunocasp-3-expressing Jurkat cells for the indicated time points, and the percentages of killing were calculated

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us